Posted: 22 December 2023
Adherium Limited (ASX:ADR) a leader in digital health technologies has delivered the first purchase order agreement of 1,750 of its next generation Hailie® Smartinhaler® sensors to major US hospital system, Intermountain Health.
This sale reflects Adherium’s recently announced commercialisation focus on strategic, value sharing partnerships with large scale US healthcare providers and insurers.
Intermountain includes 33 hospitals, 385 clinics with more than 12,000 associated physicians. Intermountain is a leader in outpatient respiratory care with around 300,000 chronic obstructive pulmonary disease (COPD) and asthma patients.
Haile’s unique next generation sensors remotely capture when and how an inhaler is being used, profoundly improving adherence and patient self-management. This data enables timely interventions and tailored treatments to improve health outcomes to reduce hospital admissions and ultimately healthcare costs.
The advanced features of the next generation Hailie sensors include inhalation flow rate, inspiratory flow duration, inhaled volume and other metrics which are valuable information about patients’ prescribed medication reaching their lungs. Hailie is the only US FDA 510(k) cleared, drug-agnostic digital sensor available today providing physiological data insights on inhaler technique.
Intermountain Health’s purchase of Hailie Smartinhalers is part of their commitment to improving patient experiences and health outcomes through integrating emerging e-health technology.
Hailie enables doctors to bill for long-term, remote patient management under established US reimbursement codes. Adherium is paid for sensor sales and receives monthly, per patient fees for generating and transmitting respiratory data.
“We are delighted with this significant purchase from Intermountain Health further expanding our footprint and establishing a new strategic partner in the US market,” said Rick Legleiter, CEO of Adherium.
“It’s pleasing to see the growing recognition and trust in the value of Adherium’s respiratory health technology.”
